{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:49:57Z","timestamp":1789944597848,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UM1-CA186690"],"award-info":[{"award-number":["UM1-CA186690"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA47904"],"award-info":[{"award-number":["P30-CA47904"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00280-016-3200-x","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T06:16:41Z","timestamp":1479795401000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies"],"prefix":"10.1007","volume":"79","author":[{"given":"Charles A.","family":"Kunos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Beumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sznol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Percy","family":"Ivy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,22]]},"reference":[{"key":"3200_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev.bi.48.070179.001025","volume":"48","author":"L Thelander","year":"1979","unstructured":"Thelander L, Reichard P (1979) Reduction of ribonucleotides. Annu Rev Biochem 48:133\u2013158. doi:\n                    10.1146\/annurev.bi.48.070179.001025","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"3200_CR2","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1158\/1078-0432.CCR-05-2860","volume":"12","author":"CA Barker","year":"2006","unstructured":"Barker CA, Burgan WE, Carter DJ, Cerna D, Gius D, Hollingshead MG, Camphausen K, Tofilon PJ (2006) In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone). Clin Cancer Res 12(9):2912\u20132918. doi:\n                    10.1158\/1078-0432.ccr-05-2860","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3200_CR3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1667\/RR1858.1","volume":"172","author":"CA Kunos","year":"2009","unstructured":"Kunos CA, Chiu SM, Pink J, Kinsella TJ (2009) Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein. Radiat Res 172(6):666\u2013676. doi:\n                    10.1667\/rr1858.1","journal-title":"Radiat Res"},{"issue":"5","key":"3200_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1667\/RR2273.1","volume":"174","author":"CA Kunos","year":"2010","unstructured":"Kunos CA, Radivoyevitch T, Pink J, Chiu SM, Stefan T, Jacobberger J, Kinsella TJ (2010) Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers. Radiat Res 174(5):574\u2013581. doi:\n                    10.1667\/rr2273.1","journal-title":"Radiat Res"},{"issue":"5","key":"3200_CR5","first-page":"980","volume":"63","author":"L Xue","year":"2003","unstructured":"Xue L, Zhou B, Liu X, Qiu W, Jin Z, Yen Y (2003) Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits. Cancer Res 63(5):980\u2013986","journal-title":"Cancer Res"},{"issue":"12","key":"3200_CR6","doi-asserted-by":"publisher","first-page":"7834","DOI":"10.1074\/jbc.M512894200","volume":"281","author":"P Hakansson","year":"2006","unstructured":"Hakansson P, Hofer A, Thelander L (2006) Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells. J Biol Chem 281(12):7834\u20137841. doi:\n                    10.1074\/jbc.M512894200","journal-title":"J Biol Chem"},{"issue":"1472","key":"3200_CR7","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1098\/rstb.2006.1874","volume":"361","author":"SY Reece","year":"2006","unstructured":"Reece SY, Hodgkiss JM, Stubbe J, Nocera DG (2006) Proton-coupled electron transfer: the mechanistic underpinning for radical transport and catalysis in biology. Philos Trans R Soc Lond B Biol Sci 361(1472):1351\u20131364. doi:\n                    10.1098\/rstb.2006.1874","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"3","key":"3200_CR8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nsmb.2007","volume":"18","author":"JW Fairman","year":"2011","unstructured":"Fairman JW, Wijerathna SR, Ahmad MF, Xu H, Nakano R, Jha S, Prendergast J, Welin RM, Flodin S, Roos A, Nordlund P, Li Z, Walz T, Dealwis CG (2011) Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization. Nat Struct Mol Biol 18(3):316\u2013322. doi:\n                    10.1038\/nsmb.2007","journal-title":"Nat Struct Mol Biol"},{"issue":"9","key":"3200_CR9","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1097\/IGC.0b013e318270577f","volume":"22","author":"CA Kunos","year":"2012","unstructured":"Kunos CA, Radivoyevitch T, Kresak A, Dawson D, Jacobberger J, Yang B, Abdul-Karim FW (2012) Elevated ribonucleotide reductase levels associate with suppressed radiochemotherapy response in human cervical cancers. Int J Gynecol Cancer 22(9):1463\u20131469. doi:\n                    10.1097\/IGC.0b013e318270577f","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"3200_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/IGC.0b013e31828b4eb5","volume":"23","author":"CA Kunos","year":"2013","unstructured":"Kunos CA, Winter K, Dicker AP, Small W Jr, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB, Gaffney DK (2013) Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. Int J Gynecol Cancer 23(4):615\u2013621. doi:\n                    10.1097\/IGC.0b013e31828b4eb5","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"3200_CR11","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.jinorgbio.2011.07.003","volume":"105","author":"A Popovic-Bijelic","year":"2011","unstructured":"Popovic-Bijelic A, Kowol CR, Lind ME, Luo J, Himo F, Enyedy EA, Arion VB, Graslund A (2011) Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study. J Inorg Biochem 105(11):1422\u20131431. doi:\n                    10.1016\/j.jinorgbio.2011.07.003","journal-title":"J Inorg Biochem"},{"issue":"4","key":"3200_CR12","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1158\/1078-0432.CCR-09-2469","volume":"16","author":"CA Kunos","year":"2010","unstructured":"Kunos CA, Waggoner S, von Gruenigen V, Eldermire E, Pink J, Dowlati A, Kinsella TJ (2010) Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer. Clin Cancer Res 16(4):1298\u20131306. doi:\n                    10.1158\/1078-0432.ccr-09-2469","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3200_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ygyno.2013.04.019","volume":"130","author":"CA Kunos","year":"2013","unstructured":"Kunos CA, Radivoyevitch T, Waggoner S, Debernardo R, Zanotti K, Resnick K, Fusco N, Adams R, Redline R, Faulhaber P, Dowlati A (2013) Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers. Gynecol Oncol 130(1):75\u201380. doi:\n                    10.1016\/j.ygyno.2013.04.019","journal-title":"Gynecol Oncol"},{"key":"3200_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fonc.2014.00184","volume":"4","author":"CA Kunos","year":"2014","unstructured":"Kunos CA, Sherertz TM (2014) Long-term disease control with triapine-based radiochemotherapy for patients with stage IB2-IIIB cervical cancer. Front Oncol 4:184. doi:\n                    10.3389\/fonc.2014.00184","journal-title":"Front Oncol"},{"key":"3200_CR15","unstructured":"Murren J, Modiano M, Plezia P, Doyon A, Bagulho T, Johnson B, Sznol M (2003) A phase I study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine) in combination with cisplatin (CDDP). In: Proceedings American society clinical oncology 22:160a (abstract 643)"},{"issue":"3","key":"3200_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"3200_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1479-5876-10-79","volume":"10","author":"C Kunos","year":"2012","unstructured":"Kunos C, Radivoyevitch T, Abdul-Karim FW, Fanning J, Abulafia O, Bonebrake AJ, Usha L (2012) Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a gynecologic oncology group study. J Transl Med 10:79. doi:\n                    10.1186\/1479-5876-10-79","journal-title":"J Transl Med"},{"issue":"4","key":"3200_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1667\/RR2556.1","volume":"176","author":"CA Kunos","year":"2011","unstructured":"Kunos CA, Ferris G, Pyatka N, Pink J, Radivoyevitch T (2011) Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers. Radiat Res 176(4):425\u2013433","journal-title":"Radiat Res"},{"issue":"2","key":"3200_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2217\/fon.11.147","volume":"8","author":"CA Kunos","year":"2012","unstructured":"Kunos CA, Radivoyevitch T, Ingalls ST, Hoppel CL (2012) Management of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone-induced methemoglobinemia. Future Oncol 8(2):145\u2013150. doi:\n                    10.2217\/fon.11.147\n                    \n                   \n                           (London, England)","journal-title":"Future Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3200-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-016-3200-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3200-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:24:28Z","timestamp":1589628268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-016-3200-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,22]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["3200"],"URL":"https:\/\/doi.org\/10.1007\/s00280-016-3200-x","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,22]]},"assertion":[{"value":"4 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}